LEVETIRACETAM ACCORD 250 mg, film-coated tablet 60 tablets, CIP 3400922381480
Active ingredients: (S)-etiracetam
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet60 tablets, CIP 3400922381480orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEVETIRACETAM ACCORD 250 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 60 plaquette(s) thermoformée(s) PVC-Aluminium de 1 comprimé(s)
- Marketing authorisation holder
- ACCORD HEALTHCARE (ESPAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Oct 2012
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63387539CIP72238148CIP133400922381480Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LÉVÉTIRACÉTAMcomprimé | 250 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.